Article citationsMore>>

T. Satoh, M. Hatae, Y. Watanabe, N. Yaegashi, O. Ishiko, S. Kodama, S. Yamaguchi, K. Ochiai, M. Takano, H. Yokota, Y. Kawakami, S. Nishimura, D. Ogishima, S. Nakagawa, H. Kobayashi, T. Shiozawa, T. Nakanishi, T. Kamura, I. Konishi and H. Yoshikawa, “Outcomes of Fertility-Sparing Surgery for Stage I Epithelial Ovarian Cancer: A Proposal for Patient Selection,” Journal of Clinical Oncology, Vol. 28, No. 10, 2010, pp. 1727-1732. doi:10.1200/JCO.2009.24.8617

has been cited by the following article:

• TITLE: Postrecurrence Clinical Outcome of Patients with Stage I Epithelial Ovarian Cancer Who Underwent Fertility-Sparing Surgery Compared to Those with Radical Surgery

  AUTHORS: Hiroaki Kajiyama, Kiyosumi Shibata, Mika Mizuno, Eiko Yamamoto, Michiyasu Kawai, Tetsuro Nagasaka, Fumitaka Kikkawa

  KEYWORDS: Recurrent Ovarian Cancer; Fertility-Sparing Surgery; Overall Survival; Postrecurrence Survival;

  JOURNAL NAME: Surgical Science, Vol.4 No.1, January 29, 2013

  ABSTRACT: Background: To examine the difference in the survival of patients with recurrent ovarian cancer who received fertility-sparing surgery (FSS) and those receiving radical surgery. Methods: Clinicopathologic data on a total of 90 patients with stage I recurrent ovarian cancer collected under the central pathological review system were subjected to survival analyses. Patients were divided into 2 groups: 1) FSS (N = 11), 2) Radical (N = 79). Results: Five-year overall survival rates of patients in the two groups were as follows: 40.8% (FSS)/44.2% (Radical), respectively. There was no significant difference in overall survival among the groups (P = 0.887). Additionally, three-year postrecurrence survival rates of patients in the two groups were 24.8% (FSS) and 25.3% (Radical) (P = 0.730). Furthermore, we accumulated 137 patients {FSS (N = 58), Radical group (N = 79)} with stage I recurrent ovarian cancer from the current study and six representative reports in the literature. Patients who experienced recurrence in the remaining ovary alone (FSS) showed a more favorable prognosis than those who had extra-ovarian site recurrence (overall survival: P = 0.021, postrecurrence survival: P = 0.069). Conclusions: Although our retrospective analysis was very preliminary, we could propose the hypothesis that patients with stage I recurrent ovarian cancer who undergo FSS may not show poorer survival rates than patients who receive radical surgery.